Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

被引:89
|
作者
Stassen, HH [1 ]
Angst, J [1 ]
DeliniStula, A [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD,CNS MED RES,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1055/s-2007-979551
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The onset of action of antidepressant drugs was investigated on the basis of two independent, multicenter, double-blind studies, comparing amitriptyline (N = 120), oxaprotiline (N = 120), imipramine (N = 506) and moclobemide (N = 580) with placebo (N = 189 /+ 191). Highly significant differences between the active drugs and placebo were found with respect to the total number of improvers and the total number of responders. In addition, significant differences between treatment modalities showed up in both the percentage rate and the time distribution of premature withdrawals. However, among improvers, the distribution of time spans to onset of improvement was found to be independent of treatment modality, indicated by virtual ly identical cumulative percentages of improvers over the whole observation period. This picture of treatment-independent improvement rates was essentially the same for the HAMD, HAMA and ZUNG assessments, except for a significant time lag between observerratings and selfratings. Specifically, our analyses revealed no evidence for a delayed onset of action of various antidepressants with large biochemical and pharmacological differences when compared to placebo. The early onset of improvement was highly predictive of later outcome: on average, 70% of patients showing improvement within the first 14 days became responders. Differences between active treatments and placebo emerged within the first five days and reached a point of maximum distinction around day 14. After this time point, differences between treatment modalities remained constant until the end of the observation period. Not more than 20 - 25% of patients were, on average, ''true'' drug responders, thus suggesting that the therapeutic qualities of antidepressants do not lie in the suppression of symptoms, but rather relate to their ability to elicit and maintain certain conditions which enable recovery in a subgroup of patients who would otherwise remain nonresponders.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [31] Onset of action of antidepressants: results of different analyses
    Thompson, C
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2002, 17 : S27 - S32
  • [32] Climate change action as a project of identity: Eight meta-analyses
    Vesely, Stepan
    Masson, Torsten
    Chokrai, Parissa
    Becker, Anna M.
    Fritsche, Immo
    Kloeckner, Christian A.
    Tiberio, Lorenza
    Carrus, Giuseppe
    Panno, Angelo
    GLOBAL ENVIRONMENTAL CHANGE-HUMAN AND POLICY DIMENSIONS, 2021, 70
  • [33] Overlapping meta-analyses on the same topic: survey of published studies
    Siontis, Konstantinos C.
    Hernandez-Boussard, Tina
    Ioannidis, John P. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [34] The effects of excluding treatments from network meta-analyses: survey
    Mills, Edward J.
    Kanters, Steve
    Thorlund, Kristian
    Chaimani, Anna
    Veroniki, Areti-Angeliki
    Ioannidis, John P. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [35] A META-EPIDEMIOLOGICAL SURVEY OF THE REPORTING OF EFFECT MODIFICATION IN NETWORK META-ANALYSES
    Kovic, B.
    Zoratti, M.
    Michalopoulos, S.
    Silvestre, C.
    Thorlund, K.
    Thabane, L.
    VALUE IN HEALTH, 2017, 20 (05) : A330 - A330
  • [36] Antidepressant Exposure During Pregnancy and Risk of Autism in the Offspring, 1: Meta-Review of Meta-Analyses
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (08) : E1047 - E1051
  • [37] Coding Errors in Study of Meta-analyses With Falsified Data in the Results
    Garmendia, Craig A.
    JAMA INTERNAL MEDICINE, 2021, 181 (03) : 408 - 409
  • [38] Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation
    Brodie, Martin J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 630 - 631
  • [39] Heterogeneity and meta-analyses: do study results truly differ?
    Virgili, Gianni
    Conti, Andrea A.
    Moja, Lorenzo
    Gensini, Gian Franco
    Gusinu, Roberto
    INTERNAL AND EMERGENCY MEDICINE, 2009, 4 (05) : 423 - 427
  • [40] Comparing results of large clinical trials to those of meta-analyses
    Moses, LE
    Mosteller, F
    Buehler, JH
    STATISTICS IN MEDICINE, 2002, 21 (06) : 793 - 800